Seeing Is Believing
Currently out of the existing stock ratings of Jason Bednar, 232 are a BUY (77.33%), 60 are a HOLD (20%), 8 are a SELL (2.67%).
Analyst Jason Bednar, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 48.72% that have a potential upside of 21.84% achieved within 116 days.
Jason Bednar’s has documented 629 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVCR, Novocure Ltd at 27-Jun-2025.
Analyst best performing recommendations are on VAPO (VAPOTHERM).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 11/3/2022. The price target of $8 was fulfilled within 1 day with a profit of $2.08 (20.63%) receiving and performance score of 206.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$220
$17.72 (8.76%)
$200
5 days ago
(08-Jul-2025)
6/15 (40%)
$19.52 (9.74%)
239
Buy
$250
$47.72 (23.59%)
$235
2 months 13 days ago
(30-Apr-2025)
14/37 (37.84%)
$73.26 (41.45%)
93
Buy
$245
$42.72 (21.12%)
$250
2 months 15 days ago
(28-Apr-2025)
11/13 (84.62%)
$67.25 (37.83%)
332
Hold
$215
$12.72 (6.29%)
$230
2 months 20 days ago
(23-Apr-2025)
10/17 (58.82%)
$30.73 (16.68%)
123
Buy
$255
$52.72 (26.06%)
$260
5 months ago
(13-Feb-2025)
9/13 (69.23%)
$50.11 (24.46%)
89
Which stock is Jason Bednar is most bullish on?
Which stock is Jason Bednar is most reserved on?
What Year was the first public recommendation made by Jason Bednar?